NK
Niravkumar Kirtikumar Mehta
About Niravkumar Kirtikumar Mehta
Data last updated:
Niravkumar Kirtikumar Mehta is a Managing Director at Corona Remedies Limited (since 2007) and Designated Partner at Nkm Nextgen Llp (since 2024). The companies operate in Pharma. The largest current company by reported revenue is Corona Remedies Limited at ₹1,202 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Corona Remedies Limited L24231GJ2004PLC044656 | Managing Director | 30 May 2007 | 2004 | ₹1,202 Cr (FY 2025) | Active |
 Nkm Nextgen Llp ACJ-8715 | Designated Partner | 10 Oct 2024 | 2024 | Active |
Board colleagues of Niravkumar Kirtikumar Mehta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ameetkumar Hiranyakumar Desai | 00007116 | Corona Remedies Limited | Director |
| Ankur Kirtikumar Mehta | 00385547 | Corona Remedies Limited | Managing Director |
| Bhaskar Vemban Iyer | 00480341 | Corona Remedies Limited | Director |
| Bhavin Nareshbhai Bhagat | Corona Remedies Limited | Cfo | |
| Chetna Prabhatkumar Dharajiya | Corona Remedies Limited | Company Secretary | |
| Kirtikumar Laxmidas Mehta | 00385658 | Corona Remedies Limited | Director |
| Monica Hemal Kanuga | 06919996 | Corona Remedies Limited | Director |
| Shirish Gundopant Belapure | 02219458 | Corona Remedies Limited | Director |
| Viral Sitwala | 02907957 | Corona Remedies Limited | Whole-Time Director |
| Dipaben Mehta | 00386067 | Nkm Nextgen Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Niravkumar Kirtikumar Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Niravkumar Kirtikumar Mehta
Niravkumar Kirtikumar Mehta currently holds 2 directorships: Corona Remedies Limited (Managing Director, since 30 May 2007, revenue ₹1,202 Cr (FY 2025)); Nkm Nextgen Llp (Designated Partner, since 10 Oct 2024).
Niravkumar Kirtikumar Mehta was first appointed on 30 May 2007 as Managing Director at Corona Remedies Limited. The most recent appointment on record is 10 Oct 2024 at Nkm Nextgen Llp.
The current boards of Niravkumar Kirtikumar Mehta's companies include Ameetkumar Hiranyakumar Desai (Corona Remedies Limited), Ankur Kirtikumar Mehta (Corona Remedies Limited), Bhaskar Vemban Iyer (Corona Remedies Limited), Bhavin Nareshbhai Bhagat (Corona Remedies Limited), Chetna Prabhatkumar Dharajiya (Corona Remedies Limited), Kirtikumar Laxmidas Mehta (Corona Remedies Limited), among others.